Development of novel fluorinated reagents for preparation of drugs.

Project Information

FLUNOVELTY

Grant agreement ID: 654260

DOI 10.3030/654260

Project closed

EC signature date 26 March 2015

Start date 1 November 2015

End date 31 October 2016

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 92 538,00

EU contribution € 92 538,00

Coordinated by

ECOLE SUPERIEURE DE PHYSIQUE ET DECHIMIE INDUSTRIELLES DE LA VILLE DEPARIS
France

Objective

Around 20% of all modern drugs are fluorinated organic molecules. During the recent years, however, pharmaceutical companies struggle to deliver novel drugs to the market, because of the lack of innovative practical reagents and reactions towards “drug-like” compounds.
In this project, we will address this issue by discovering novel small fluorinating reagents - fluorinated diazoalkanes, - elaborate their practical reactions, and use this knowledge to develop alternative synthetic approaches to some known drugs (AS-136A, Celecoxib).

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs

Programme(s)

• H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions Main Programme
• H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility

Topic(s)

• MSCA-IF-2014-EF - Marie Skłodowska-Curie Individual Fellowships (IF-EF)

Call for proposal

H2020-MSCA-IF-2014

Funding Scheme

MSCA-IF-EF-ST - Standard EF

Coordinator

ECOLE SUPERIEURE DE PHYSIQUE ET DECHIMIE INDUSTRIELLES DE LA VILLE DEPARIS

• Net EU contribution: € 92 538,00
• Address: RUE VAUQUELIN 10 ; 75231 Paris ; France
• Region: Ile-de-France › Ile-de-France › Paris
• Activity type: Higher or Secondary Education Establishments
• Total cost: € 92 538,00